Publications

  1. Brunel J, Chopy D, Dosnon M, Bloyet LM, Devaux P, Urzua E, Cattaneo R, Longhi S, Gerlier D. Sequence of events in measles virus replication: role of phosphoprotein-nucleocapsid interactions. J Virol. 2014 Sep 15; 88(18):10851-63. Epub 2014 Jul 09.
    View PubMed
  2. Devaux P, Priniski L, Cattaneo R. The measles virus phosphoprotein interacts with the linker domain of STAT1. Virology. 2013 Sep; 444(1-2):250-6. Epub 2013 Jul 13.
    View PubMed
  3. Devaux P, Hudacek AW, Hodge G, Reyes-Del Valle J, McChesney MB, Cattaneo R. A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys. J Virol. 2011 Jan; 85(1):348-56. Epub 2010 Oct 27.
    View PubMed
  4. McAllister CS, Toth AM, Zhang P, Devaux P, Cattaneo R, Samuel CE. Mechanisms of protein kinase PKR-mediated amplification of beta interferon induction by C protein-deficient measles virus. J Virol. 2010 Jan; 84(1):380-6.
    View PubMed
  5. Toth AM, Devaux P, Cattaneo R, Samuel CE. Protein kinase PKR mediates the apoptosis induction and growth restriction phenotypes of C protein-deficient measles virus. J Virol. 2009 Jan; 83(2):961-8. Epub 2008 Nov 12.
    View PubMed
  6. Leonard VH, Sinn PL, Hodge G, Miest T, Devaux P, Oezguen N, Braun W, McCray PB Jr, McChesney MB, Cattaneo R. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J Clin Invest. 2008 Jul; 118(7):2448-58.
    View PubMed
  7. Devaux P, Hodge G, McChesney MB, Cattaneo R. Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys. J Virol. 2008 Jun; 82(11):5359-67. Epub 2008 Apr 02.
    View PubMed
  8. del Valle JR, Devaux P, Hodge G, Wegner NJ, McChesney MB, Cattaneo R. A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. J Virol. 2007 Oct; 81(19):10597-605. Epub 2007 Jul 18.
    View PubMed
  9. Condack C, Grivel JC, Devaux P, Margolis L, Cattaneo R. Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis. 2007 Aug 15; 196(4):541-9. Epub 2007 Jun 29.
    View PubMed
  10. Devaux P, von Messling V, Songsungthong W, Springfeld C, Cattaneo R. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology. 2007 Mar 30; 360(1):72-83. Epub 2006 Nov 16.
    View PubMed
  11. Cruz CD, Palosaari H, Parisien JP, Devaux P, Cattaneo R, Ouchi T, Horvath CM. Measles virus V protein inhibits p53 family member p73. J Virol. 2006 Jun; 80(11):5644-50.
    View PubMed
  12. Devaux P, Cattaneo R. Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function. J Virol. 2004 Nov; 78(21):11632-40.
    View PubMed
  13. von Messling V, Milosevic D, Devaux P, Cattaneo R. Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function. J Virol. 2004 Aug; 78(15):7894-903.
    View PubMed
  14. Devaux P, Christiansen D, Plumet S, Gerlier D. Cell surface activation of the alternative complement pathway by the fusion protein of measles virus. J Gen Virol. 2004 Jun; 85(Pt 6):1665-73.
    View PubMed
  15. von Messling V, Springfeld C, Devaux P, Cattaneo R. A ferret model of canine distemper virus virulence and immunosuppression. J Virol. 2003 Dec; 77(23):12579-91.
    View PubMed
  16. Schneider U, von Messling V, Devaux P, Cattaneo R. Efficiency of measles virus entry and dissemination through different receptors. J Virol. 2002 Aug; 76(15):7460-7.
    View PubMed
  17. Christiansen D, Devaux P, Réveil B, Evlashev A, Horvat B, Lamy J, Rabourdin-Combe C, Cohen JH, Gerlier D. Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo. J Virol. 2000 May; 74(10):4672-8.
    View PubMed
  18. Devaux P, Christiansen D, Fontaine M, Gerlier D. Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation. Eur J Immunol. 1999 Mar; 29(3):815-22.
    View PubMed
  19. Buchholz CJ, Koller D, Devaux P, Mumenthaler C, Schneider-Schaulies J, Braun W, Gerlier D, Cattaneo R. Mapping of the primary binding site of measles virus to its receptor CD46. J Biol Chem. 1997 Aug 29; 272(35):22072-9.
  20. Devaux P, Buchholz CJ, Schneider U, Escoffier C, Cattaneo R, Gerlier D. CD46 short consensus repeats III and IV enhance measles virus binding but impair soluble hemagglutinin binding. J Virol. 1997 May; 71(5):4157-60.
  21. Devaux P, Gerlier D. Antibody cross-reactivity with CD46 and lack of cell surface expression suggest that moesin might not mediate measles virus binding. J Virol. 1997 Feb; 71(2):1679-82.
    View PubMed
  22. Gerlier D, Devaux P. CD46, un premier récepteur du VR de la rougeole. Virologie. 1997; 1:321-30.
  23. Devaux P, Loveland B, Christiansen D, Milland J, Gerlier D. Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry. J Gen Virol. 1996 Jul; 77(Pt 7):1477-81.
    View PubMed
  24. Buchholz CJ, Schneider U, Devaux P, Gerlier D, Cattaneo R. Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol. 1996 Jun; 70(6):3716-23.
  25. Gerlier D, Varior-Krishnan G, Devaux P. CD46-mediated measles virus entry: a first key to host-range specificity. Trends Microbiol. 1995 Sep; 3(9):338-45.
    View PubMed